AptamiR Therapeutics
Business Services · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3925 W Braker Ln, Austin, Texas, 78759, ...Phone Number
(239) 682-3791Website
www.aptamir.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About AptamiR Therapeutics
AptamiR Therapeutics is a US-based biotechnology company focused on the pre-clinical development of targeted OligoNucleotide Therapeutics (ONTs) aimed at treating cardiometabolic disorders such as obesity, diabetes, and metabolic dysfunction-associated fatty liver disease, as well as epithelial ovarian cancer. The company employs a pleiotropic strategy to develop safe and effective therapeutic agents that improve patients' quality of life without affecting brain functions. Their innovative approach includes the use of microRNA-based ONTs to simultaneously target multiple genes involved in complex diseases. AptamiR's goal is to advance their drug candidates through clinical studies and secure funding to support their mission of providing affordable treatments for unmet medical needs.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AptamiR Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if AptamiR Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once AptamiR Therapeutics has new funding data
Earning: See what the market has to say on AptamiR Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at AptamiR Therapeutics
AptamiR Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if AptamiR Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if AptamiR Therapeutics is spiking on competitors!
Product Launch: Get notified when AptamiR Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined AptamiR Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to AptamiR Therapeutics
Compare insights from companies similar to AptamiR Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AptamiR Therapeutics
<$5M
1-10
Private
-
2012
N/A
Company Profile Activity
Activity Insights
AptamiR Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AptamiR Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AptamiR Therapeutics.
AptamiR Therapeutics Tech Stack
A closer look at the technologies used by AptamiR Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AptamiR Therapeutics
Sign Up For FreeTo access detailed company insights
AptamiR Therapeutics is a US-based biotechnology company focused on the pre-clinical development of targeted OligoNucleotide Therapeutics (ONTs) aimed at treating cardiometabolic disorders such as obesity, diabetes, and metabolic dysfunction-associated fatty liver disease, as well as epithelial ovarian cancer. The company employs a pleiotropic stra... Read More
